Cargando…
Targeting the apoptotic Mcl-1-PUMA interface with a dual-acting compound
Despite intensive efforts in the search for small molecules with anti-cancer activity, it remains challenging to achieve both high effectiveness and safety, since many agents lack the selectivity to only act on cancer cells. The interface of two apoptotic proteins, myeloid cell leukemia-1 (Mcl-1) an...
Autores principales: | Liu, Jiyuan, Tian, Zhen, Zhou, Nan, Liu, Xueying, Liao, Chenyi, Lei, Beilei, Li, Jianing, Zhang, Shengyong, Chen, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589576/ https://www.ncbi.nlm.nih.gov/pubmed/28903337 http://dx.doi.org/10.18632/oncotarget.17294 |
Ejemplares similares
-
Role of non-native electrostatic interactions in the coupled folding and binding of PUMA with Mcl-1
por: Chu, Wen-Ting, et al.
Publicado: (2017) -
Phosphorylation of Puma modulates its apoptotic function by regulating protein stability
por: Fricker, M, et al.
Publicado: (2010) -
Allosteric Inhibition of Anti-Apoptotic MCL-1
por: Lee, Susan, et al.
Publicado: (2016) -
IRES-mediated translation of the pro-apoptotic Bcl2 family member PUMA
por: Shaltouki, Atossa, et al.
Publicado: (2013) -
The carboxyl-terminal sequence of PUMA binds to both anti-apoptotic proteins and membranes
por: Pemberton, James M, et al.
Publicado: (2023)